These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 18190326

  • 1. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM.
    Clin Infect Dis; 2007 Dec 15; 45(12):1633-9. PubMed ID: 18190326
    [Abstract] [Full Text] [Related]

  • 2. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 3. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR.
    J Infect Dis; 2004 Sep 15; 190(6):1046-54. PubMed ID: 15319852
    [Abstract] [Full Text] [Related]

  • 4. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.
    Scand J Infect Dis; 2012 Sep 15; 44(9):689-96. PubMed ID: 22680981
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, Staniland GH, Timmerman V, Msimanga M, Seebregts CJ, Boulle A, Nhiwatiwa R, Bateman ED, Zwarenstein MF, Chapman RD.
    Arch Intern Med; 2008 Jan 14; 168(1):86-93. PubMed ID: 18195200
    [Abstract] [Full Text] [Related]

  • 6. [Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients].
    Nakamura Y, Shibuya A, Suzuki H, Ando M.
    Nihon Jinzo Gakkai Shi; 2008 Jan 14; 50(4):499-505. PubMed ID: 18546881
    [Abstract] [Full Text] [Related]

  • 7. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.
    Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Goozé L, Rubin NR, Young MA, Cai X, Shi Q, Gao W, Anastos K.
    Clin Infect Dis; 2004 Oct 15; 39(8):1199-206. PubMed ID: 15486845
    [Abstract] [Full Text] [Related]

  • 8. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
    Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD, EuroSIDA Study Group.
    AIDS; 2010 Jul 17; 24(11):1667-78. PubMed ID: 20523203
    [Abstract] [Full Text] [Related]

  • 9. CKD and risk of hospitalization and death with pneumonia.
    James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR, Alberta Kidney Disease Network.
    Am J Kidney Dis; 2009 Jul 17; 54(1):24-32. PubMed ID: 19447535
    [Abstract] [Full Text] [Related]

  • 10. Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort.
    Perez JL, Moore RD.
    Clin Infect Dis; 2003 Jan 15; 36(2):212-8. PubMed ID: 12522755
    [Abstract] [Full Text] [Related]

  • 11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 12. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
    Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B.
    Am J Kidney Dis; 2008 Sep 20; 52(3):444-53. PubMed ID: 18468747
    [Abstract] [Full Text] [Related]

  • 13. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 14. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F, Spanish Pneumococcal Infection Study Network (G03/103).
    Arch Intern Med; 2005 Jul 11; 165(13):1533-40. PubMed ID: 16009870
    [Abstract] [Full Text] [Related]

  • 15. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct 11; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 16. Outcome and prognosis factors in HIV-infected hemodialysis patients.
    Tourret J, Tostivint I, du Montcel ST, Bragg-Gresham J, Karie S, Vigneau C, Guiard-Schmid JB, Deray G, Bagnis CI.
    Clin J Am Soc Nephrol; 2006 Nov 11; 1(6):1241-7. PubMed ID: 17699354
    [Abstract] [Full Text] [Related]

  • 17. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N.
    HIV Med; 2008 May 11; 9(5):300-6. PubMed ID: 18400077
    [Abstract] [Full Text] [Related]

  • 18. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.
    Clin Infect Dis; 2009 Nov 01; 49(9):1433-40. PubMed ID: 19807275
    [Abstract] [Full Text] [Related]

  • 19. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May 01; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 20. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis.
    James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR, Alberta Kidney Disease Network.
    Arch Intern Med; 2008 Nov 24; 168(21):2333-9. PubMed ID: 19029498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.